[Nibufin treatment of syringomyelia patients with motor, vasomotor and sensory disorders].
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D010710:Phosphates / Q000627:therapeutic use*; D013595:Syringomyelia / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D010710:Phosphates
O lechenii nibufinom dvigatel'nykh, vazomotornykh narusheniĭ i rasstroĭstv chuvstvitel'nosti u bol'nykh siringomielieĭ.